Biochemical Study of Bilberry Extract Potential in Preventing Retinal Damage in Rat Model of Diabetes Induced by Streptozotocin/Nicotinamide
Maja Petrović, Marija Trenkić, Marija Veselinović, Aleksandra Smiljković, Dušan Sokolović

TL;DR
This study shows that bilberry extract may help reduce retinal damage caused by diabetes in rats by lowering oxidative stress and improving certain biomarkers.
Contribution
The novel contribution is demonstrating bilberry extract's potential to mitigate oxidative retinal damage in a rat model of diabetes.
Findings
Bilberry extract significantly reduced retinal lipid peroxidation and advanced oxidized protein products in diabetic rats.
Treatment normalized the expression of VEGF and MMP-9, which are linked to vascular changes in diabetic retinopathy.
Bilberry extract partially improved lipid profile by lowering LDL cholesterol levels in diabetic rats.
Abstract
Type 2 diabetes mellitus is a growing global health concern, with diabetic retinopathy (DR) representing a major microvascular complication that contributes significantly to vision impairment. Oxidative stress plays a critical role in the pathogenesis of DR, which is associated with changes in vascularization-associated molecules, such as iNOS, VEGF, and MMP-9. The present study investigates the therapeutic potential of bilberry (Vaccinium myrtillus L.) extract—rich in anthocyanins—applied for 14 days on blood glucose levels, lipid profile, and retinal oxidative stress (lipid peroxidation (TBARS) and advanced oxidized protein products (AOPPs)) in a streptozotocin/nicotinamide (STZ/NA)-induced diabetes rat model. Results showed a significant reduction in non-fasting blood glucose, retinal TBARS, and AOPP levels, and normalization of VEGF and MMP-9 expression in bilberry-treated diabetic…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal Diseases and Treatments · Retinal Imaging and Analysis · Advanced Glycation End Products research
